SCHENECTADY, N.Y. — A man who killed his wife by dousing her with gasoline and setting her on fire during an argument has pleaded guilty to murder. The Schenectady County District Attorney’s office says 69-year-old Antonio Bargallo entered the plea Wednesday as part of a deal that will sentence him to 21 years to life...
NYS Entity Status
NYS Filing Date
MARCH 18, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY
2014 - FLEX MOVE PHYSICAL THERAPY, PLLC
Around the Web
- Man pleads guilty to killing wife by setting her on fire
By Associated Press - Thursday Jul 20, 2017
- Bots are becoming highly skilled assistants in physical therapy
By Michal Prywata, Bionik Laboratories - Sunday Oct 15, 2017
GUEST: Within the last decade, we’ve seen incredible progress in the fields of robotics and artificial intelligence. Innovators have been seeking out ways to meld man and machine and, in some areas, remove man altogether. In robotics, we’re seeing delivery drones, security robots, and more. In AI, chatbots, self-driving cars, and voice recognition have all made […]
- FDA advisers endorse gene therapy to treat form of blindness
By MATTHEW PERRONE, AP Health Writer - Thursday Oct 12, 2017
SILVER SPRING, Md. (AP) — A potentially groundbreaking treatment for a rare form of blindness moved one step closer to U.S. approval Thursday, as federal health advisers endorsed the experimental gene therapy for patients with an inherited condition that gradually destroys eyesight.The panel experts to the Food and Drug Administration voted unanimously in favor of Spark Therapeutics' injectable therapy, which aims to improve vision by replacing a defective gene needed to process light.The vote amounts to a recommendation to approve the therapy. The FDA has until mid-January to make its decision and does not have to follow the panel's recommendation, though it often does.If approved, Luxturna would be the first gene therapy in the U.S.
- FDA Approves First Gene Therapy
Wednesday Aug 30, 2017
The Food and Drug Administration has approved the first gene therapy in the U.S., a long-heralded move for a promising new method of combating cancer. The FDA approved Novartis AG’s Kymriah for certain children and young adults who suffer from a form of leukemia.
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]